The Journal of invasive cardiology · 2026
Safety and outcomes of upfront large-size rotational atherectomy burrs in left main coronary interventions.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Khan Hilal, Al-Atta Ayman, Farag Mohamed, Abdalazeem Ibrahem, Gungoren Fatih, Alkhalil Mohammad, Abdalwahab Ahmed, Holley Mia, Wilkes Scott, Bawamia Bilal, Egred Mohaned
Аннотация
OBJECTIVES: Data on the safety and efficacy of percutaneous coronary intervention (PCI) with adjunctive rotational atherectomy (RA) in left main (LM) disease are limited. Current guidelines recommend using a small-size RA burr initially, with upsizing if required. The safety of upfront use of a large-size RA burr (≥1.75 mm) is unknown. The authors assessed the safety of an upfront large rotablation burr in the treatment of LM calcification and the procedural and long-term outcome of this approach in comparison to a small-size burr.
METHODS: Retrospective analysis of all patients undergoing PCI with adjunctive RA to LM disease. The study outcomes were all-cause mortality and repeat target lesion revascularization (TLR) at medium-term follow-up in patients treated with large burr size (≥1.75mm) compared to small burr size (<1.75mm).
RESULTS: Two hundred forty-three patients (mean age 75 ± 9 years, 80% males) were included. Approximately half of the patients were treated with a large-size RA burr (≥1.75 mm). Most treated lesions were bifurcation lesions involving the 3 branches (86%) with SYNTAX score of 35 ± 11. Radial access was used in two-thirds of patients; 7F sheath was the most used. There was no difference between the small and large burr groups in procedural complications (11% vs 8%, P = .512), all-cause mortality (34% vs 28%, P = .267), and repeat TLR up to 4 years after PCI (2.9% vs 2.1%, P = .473).
CONCLUSIONS: Upfront use of a large-size RA burr is feasible and safe for treating calcified LM disease, with no increase in procedural complications, repeat TLR, or medium-term all-cause mortality.
METHODS: Retrospective analysis of all patients undergoing PCI with adjunctive RA to LM disease. The study outcomes were all-cause mortality and repeat target lesion revascularization (TLR) at medium-term follow-up in patients treated with large burr size (≥1.75mm) compared to small burr size (<1.75mm).
RESULTS: Two hundred forty-three patients (mean age 75 ± 9 years, 80% males) were included. Approximately half of the patients were treated with a large-size RA burr (≥1.75 mm). Most treated lesions were bifurcation lesions involving the 3 branches (86%) with SYNTAX score of 35 ± 11. Radial access was used in two-thirds of patients; 7F sheath was the most used. There was no difference between the small and large burr groups in procedural complications (11% vs 8%, P = .512), all-cause mortality (34% vs 28%, P = .267), and repeat TLR up to 4 years after PCI (2.9% vs 2.1%, P = .473).
CONCLUSIONS: Upfront use of a large-size RA burr is feasible and safe for treating calcified LM disease, with no increase in procedural complications, repeat TLR, or medium-term all-cause mortality.